Pyeonghwa Jeong
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Pyeonghwa Jeong has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
- Jiyong Hong
Department of Chemistry, Duke University, Durham, USA
5 shared publications - Brenda C. Shields
Duke University
2 shared publications - C. Skyler Cochrane
Department of Biochemistry, Duke University School of Medicine, Durham, NC, 27710, USA
2 shared publications - Christina Holmboe Olesen
Copenhagen Hepatitis C Program (CO-HEP), Department of Infectious Diseases, Copenhagen University Hospital, Hvidovre, Denmark
2 shared publications - Eleni Tapp
Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Berlin, Germany
2 shared publications - Johannes Broichhagen
Leibniz‐Forschungsinstitut für Molekulare Pharmakologie Berlin Germany
2 shared publications
Latest Publications
- Open Access
Identification of 4,5,6,7-Tetrabromo-1 H -benzotriazole (TBB) as a Small Molecule MESH1 Inhibitor that Suppresses Ferroptosis
Ferroptosis is a regulated form of cell death driven by iron-dependent lipid peroxidation and contributes to diverse pathologies including ischemia-reperfusion injury and neurodegenerative disorders. Current ferroptosis inhibitors largely function as nonspecific radical-trapping antioxidants, limiting their clinical utility. We previously identified MESH1 as a key regulator of ferroptosis through its NADPH phosphatase activity. Here, we identify 4,5,6,7-tetrabromo-1 H -benzotriazole (TBB) as a small molecule inhibitor of MESH1 with an IC 50 value of 4.7 ± 0.3 µM. X-ray crystallography revealed the molecular determinants of TBB recognition which are corroborated through structure-activity relationships of TBB analogs. TBB protected multiple cell lines against ferroptosis in vitro , and this effect was mitigated by MESH1 knockdown, consistent with on-target activity. Furthermore, TBB reduced neuronal death in an ex vivo brain slice model of Alzheimer’s disease. Collectively, these findings establish TBB as a bona fide small-molecule MESH1 inhibitor that suppresses ferroptosis and establishes MESH1 as a promising therapeutic target. Graphical Depicting mechanism of TBB suppressing ferroptosis through the inhibition of MESH1. Figure Created with Biorender.com
Open AccessIdentification of 4,5,6,7-Tetrabromo-1 H -benzotriazole (TBB) as a Small Molecule MESH1 Inhibitor that Suppresses Ferroptosis
Ferroptosis is a regulated form of cell death driven by iron-dependent lipid peroxidation and contributes to diverse pathologies including ischemia-reperfusion injury and neurodegenerative disorders. Current ferroptosis inhibitors largely function as nonspecific radical-trapping antioxidants, limiting their clinical utility. We previously identified MESH1 as a key regulator of ferroptosis through its NADPH phosphatase activity. Here, we identify 4,5,6,7-tetrabromo-1 H -benzotriazole (TBB) as a small molecule inhibitor of MESH1 with an IC 50 value of 4.7 ± 0.3 µM. X-ray crystallography revealed the molecular determinants of TBB recognition which are corroborated through structure-activity relationships of TBB analogs. TBB protected multiple cell lines against ferroptosis in vitro , and this effect was mitigated by MESH1 knockdown, consistent with on-target activity. Furthermore, TBB reduced neuronal death in an ex vivo brain slice model of Alzheimer’s disease. Collectively, these findings establish TBB as a bona fide small-molecule MESH1 inhibitor that suppresses ferroptosis and establishes MESH1 as a promising therapeutic target. Graphical Depicting mechanism of TBB suppressing ferroptosis through the inhibition of MESH1. Figure Created with Biorender.com
- Open Access
- 12 January 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1) , 426
A general one-step protocol to generate impermeable fluorescent HaloTag substrates for in situ live cell application and super-resolution imaging
Visualization of proteins can be achieved by genetically grafting HaloTag Protein (HTP) into the protein of interest followed by incubation with a dye-linked HaloTag Ligand (HTL). This approach allows for use of fluorophores optimized for specific optical techniques or of cell-impermeable dyes to selectively label cell surface proteins. However, these two goals often conflict, as many high-performing dyes exhibit membrane permeability. Here we show that several dye-HTL reagents can be made cell-impermeable by inserting a charged sulfonate directly into the HTL, leaving the dye moiety unperturbed, using a one-step protocol. We validate such compounds, termed dye-SHTL (dye shuttle), in living cells, and demonstrate exclusive membrane staining. In transduced primary hippocampal neurons, we label a neuromodulatory receptor with dyes optimized for stimulated emission by depletion super-resolution microscopy, allowing accuracy in distinguishing surface versus internal receptors of the presynaptic terminal. This approach offers broad utility for surface-specific protein labelling.
- 12 January 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1) , 426
Open AccessA general one-step protocol to generate impermeable fluorescent HaloTag substrates for in situ live cell application and super-resolution imaging
Visualization of proteins can be achieved by genetically grafting HaloTag Protein (HTP) into the protein of interest followed by incubation with a dye-linked HaloTag Ligand (HTL). This approach allows for use of fluorophores optimized for specific optical techniques or of cell-impermeable dyes to selectively label cell surface proteins. However, these two goals often conflict, as many high-performing dyes exhibit membrane permeability. Here we show that several dye-HTL reagents can be made cell-impermeable by inserting a charged sulfonate directly into the HTL, leaving the dye moiety unperturbed, using a one-step protocol. We validate such compounds, termed dye-SHTL (dye shuttle), in living cells, and demonstrate exclusive membrane staining. In transduced primary hippocampal neurons, we label a neuromodulatory receptor with dyes optimized for stimulated emission by depletion super-resolution microscopy, allowing accuracy in distinguishing surface versus internal receptors of the presynaptic terminal. This approach offers broad utility for surface-specific protein labelling.
- 27 October 2025
- Published by American Chemical Society (ACS) in ACS Infectious Diseases
- Vol. 11 (11) , 2993-3008
From Obscurity to Opportunity: LpxH Emerges as a Promising Antibiotic Target in the Battle against Gram-Negative Pathogens
The surging crisis of multidrug-resistant Gram-negative pathogens underscores the urgent need for antibiotics with novel mechanisms of action. A promising strategy is to target previously unexploited pathways, such as lipid A biosynthesis. Lipid A functions as the membrane anchor of lipopolysaccharide and constitutes the outer monolayer of the outer membrane of Gram-negative bacteria. LpxH, a Mn2+-dependent phosphoesterase, catalyzes the conversion of UDP-2,3-diacylglucosamine to lipid X, a key precursor in lipid A production. Disruption of this essential step compromises outer membrane integrity, leading to bacterial death, making LpxH an attractive antibiotic target. Since AstraZeneca's discovery of the first small-molecule LpxH inhibitor a decade ago, research has progressed substantially. The development of nonradioactive LpxH activity assays has enabled rapid screening and characterization of inhibitors. Structural and biochemical studies have revealed the architecture of LpxH and dynamic properties of the bound inhibitors, informing structure- and dynamics-based inhibitor design. Notably, recent breakthroughs from academic institutions and pharmaceutical companies have produced LpxH inhibitors with potent antibacterial activity against wild-type Enterobacterales in both in vitro and in vivo models. This review describes the biological role of LpxH and its paralogs, highlights recent advances in assay development and structural analysis, and surveys the current landscape of LpxH-targeting compounds in preclinical development. These collective advances establish LpxH as a novel target in the battle against multidrug-resistant Gram-negative infections and highlight a promising therapeutic opportunity that could reinvigorate the antibiotic pipeline.
- 27 October 2025
- Published by American Chemical Society (ACS) in ACS Infectious Diseases
- Vol. 11 (11) , 2993-3008
From Obscurity to Opportunity: LpxH Emerges as a Promising Antibiotic Target in the Battle against Gram-Negative Pathogens
The surging crisis of multidrug-resistant Gram-negative pathogens underscores the urgent need for antibiotics with novel mechanisms of action. A promising strategy is to target previously unexploited pathways, such as lipid A biosynthesis. Lipid A functions as the membrane anchor of lipopolysaccharide and constitutes the outer monolayer of the outer membrane of Gram-negative bacteria. LpxH, a Mn2+-dependent phosphoesterase, catalyzes the conversion of UDP-2,3-diacylglucosamine to lipid X, a key precursor in lipid A production. Disruption of this essential step compromises outer membrane integrity, leading to bacterial death, making LpxH an attractive antibiotic target. Since AstraZeneca's discovery of the first small-molecule LpxH inhibitor a decade ago, research has progressed substantially. The development of nonradioactive LpxH activity assays has enabled rapid screening and characterization of inhibitors. Structural and biochemical studies have revealed the architecture of LpxH and dynamic properties of the bound inhibitors, informing structure- and dynamics-based inhibitor design. Notably, recent breakthroughs from academic institutions and pharmaceutical companies have produced LpxH inhibitors with potent antibacterial activity against wild-type Enterobacterales in both in vitro and in vivo models. This review describes the biological role of LpxH and its paralogs, highlights recent advances in assay development and structural analysis, and surveys the current landscape of LpxH-targeting compounds in preclinical development. These collective advances establish LpxH as a novel target in the battle against multidrug-resistant Gram-negative infections and highlight a promising therapeutic opportunity that could reinvigorate the antibiotic pipeline.
- Open Access
- 2 October 2025
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 10 (40) , 47623-47630
Asymmetric Synthesis of the TRPV1 Modulator AMG8562 via Lipase-Catalyzed Kinetic Resolution
The transient receptor potential vanilloid-1 (TRPV1) channel is a key mediator of pain perception and responds to various stimuli such as heat, low pH, and inflammation. Among TRPV1 antagonists, (R,E)-N-(2-hydroxy-2,3-dihydro-1H-inden-4-yl)-3-(2-(piperidin-1-yl)-4-(trifluoromethyl)-phenyl)-acrylamide (AMG8562) shows promise as a nonopioid analgesic, attenuating pain behaviors in rodent models without eliciting hyperthermic side effects commonly associated with other TRPV1 antagonists. Despite its potential, there has been limited research regarding the synthesis of AMG8562. Here, we present an asymmetric synthesis of AMG8562 featuring a lipase-catalyzed kinetic resolution of racemic 4-nitroindan-2-ol. This approach enables scalable access to enantiomerically pure material and provides a platform for the synthesis of structurally diverse AMG8562 analogues with potential for improved pharmacological properties.
- 2 October 2025
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 10 (40) , 47623-47630
Open AccessAsymmetric Synthesis of the TRPV1 Modulator AMG8562 via Lipase-Catalyzed Kinetic Resolution
The transient receptor potential vanilloid-1 (TRPV1) channel is a key mediator of pain perception and responds to various stimuli such as heat, low pH, and inflammation. Among TRPV1 antagonists, (R,E)-N-(2-hydroxy-2,3-dihydro-1H-inden-4-yl)-3-(2-(piperidin-1-yl)-4-(trifluoromethyl)-phenyl)-acrylamide (AMG8562) shows promise as a nonopioid analgesic, attenuating pain behaviors in rodent models without eliciting hyperthermic side effects commonly associated with other TRPV1 antagonists. Despite its potential, there has been limited research regarding the synthesis of AMG8562. Here, we present an asymmetric synthesis of AMG8562 featuring a lipase-catalyzed kinetic resolution of racemic 4-nitroindan-2-ol. This approach enables scalable access to enantiomerically pure material and provides a platform for the synthesis of structurally diverse AMG8562 analogues with potential for improved pharmacological properties.
- Open Access
A one-step protocol to generate impermeable fluorescent HaloTag substrates for in situ live cell application and super-resolution imaging
Communication between cells is largely orchestrated by proteins on the cell surface, which allow information transfer across the cell membrane. Super-resolution and single-molecule visualization of these proteins can be achieved by genetically grafting HTP (HaloTag Protein) into the protein of interest followed by brief incubation of cells with a dye-HTL (dye-linked HaloTag Ligand). This approach allows for use of cutting-edge fluorophores optimized for specific optical techniques or a cell-impermeable dye-HTL to selectively label surface proteins without labeling intracellular copies. However, these two goals often conflict, as many high-performing dyes exhibit membrane permeability. Traditional methods to eliminate cell permeability face synthetic bottlenecks and risk altering photophysical properties. Here we report that dye-HTL reagents can be made cell-impermeable by inserting a charged sulfonate directly into the HTL, leaving the dye moiety unperturbed. This simple, one-step method requires no purification and is compatible with both the original HTL and second-generation HTL.2, the latter offering accelerated labeling. We validate such compounds, termed dye-SHTL (‘dye shuttle’) conjugates, in live cells via widefield microscopy, demonstrating exclusive membrane staining of extracellular HTP fusion proteins. In transduced primary hippocampal neurons, we label mGluR2, a neuromodulatory G protein-coupled receptor (GPCR), with dyes optimized for stimulated emission by depletion (STED) super-resolution microscopy, allowing unprecedented accuracy in distinguishing surface and receptors from those in internal compartments of the presynaptic terminal, important in neural communication. This approach offers broad utility for surface-specific protein labelling.
Open AccessA one-step protocol to generate impermeable fluorescent HaloTag substrates for in situ live cell application and super-resolution imaging
Communication between cells is largely orchestrated by proteins on the cell surface, which allow information transfer across the cell membrane. Super-resolution and single-molecule visualization of these proteins can be achieved by genetically grafting HTP (HaloTag Protein) into the protein of interest followed by brief incubation of cells with a dye-HTL (dye-linked HaloTag Ligand). This approach allows for use of cutting-edge fluorophores optimized for specific optical techniques or a cell-impermeable dye-HTL to selectively label surface proteins without labeling intracellular copies. However, these two goals often conflict, as many high-performing dyes exhibit membrane permeability. Traditional methods to eliminate cell permeability face synthetic bottlenecks and risk altering photophysical properties. Here we report that dye-HTL reagents can be made cell-impermeable by inserting a charged sulfonate directly into the HTL, leaving the dye moiety unperturbed. This simple, one-step method requires no purification and is compatible with both the original HTL and second-generation HTL.2, the latter offering accelerated labeling. We validate such compounds, termed dye-SHTL (‘dye shuttle’) conjugates, in live cells via widefield microscopy, demonstrating exclusive membrane staining of extracellular HTP fusion proteins. In transduced primary hippocampal neurons, we label mGluR2, a neuromodulatory G protein-coupled receptor (GPCR), with dyes optimized for stimulated emission by depletion (STED) super-resolution microscopy, allowing unprecedented accuracy in distinguishing surface and receptors from those in internal compartments of the presynaptic terminal, important in neural communication. This approach offers broad utility for surface-specific protein labelling.